CONTACT US TODAY: (216) 831-0600
Narrowband UVB therapy boasts an exceptional safety profile, making it suitable for children1, pregnant women2, the elderly3, and individuals with compromised immune systems.4
Furthermore, research indicates that Narrowband UVB monotherapy is not significantly linked to the development of malignant melanoma, squamous cell carcinoma, or basal cell carcinoma.5
Recent clinical trials show 89.1% of guttate psoriasis and 64.8% of plaque psoriasis patients achieved a PASI 90 clearance in less than 7 weeks (over 20 sessions) – making phototherapy an ideal choice for many patients.6
Proven Efficacy Across Various Conditions: Demonstrated effectiveness in treating psoriasis, atopic dermatitis, vitiligo, and other photoresponsive conditions.7
NatBio offers advanced, customizable solutions for both home and clinic settings. Innovations like the Digital Timer Controller and our Physicians Portal were developed to make prescribing and administering phototherapy simple. Our proprietary software and hardware collaborate seamlessly to ensure each treatment is safe, effective, and user-friendly.
Whether you prefer home-based, in-office, or a blend of both approaches, NatBio provides the equipment, technology, and expertise necessary for success.
NatBio offers reduced long-term costs compared to alternative treatments, such as ongoing oral medication or injections, which alleviate strain on the healthcare ecosystem.
Moreover, home phototherapy entails a single, affordable purchase with minimal recurring expenses, eliminating the risk of treatment interruption due to coverage alterations or financial challenges.
Earn additional revenue using in-office phototherapy and the reimbursement codes 96910 and 96900.8
Enhance in-office phototherapy capabilities by implementing a dual-path phototherapy protocol. Initiate treatment with in-clinic sessions and then transition patients to home therapy and semi-annual in-office progress checks. This approach empowers patients while enabling providers to monitor progress closely, fostering a consistent revenue stream for the practice.
NatBio is a trusted name in home phototherapy solutions, ensuring safety and efficacy for patients managing skin conditions at home. See how our devices can help your patients
For over 40 years, NatBio devices have been trusted by providers worldwide. Our clinical devices are designed for effective and efficient treatments, tailored to meet modern clinic requirements.
REFERENCES
1 Pavlovsky M, Baum S, Shpiro D, Pavlovsky L, Pavlotsky F. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis? J Eur Acad Dermatol Venereol. 2011 Jun;25(6):727-9. doi: 10.1111/j.1468-3083.2010.03832.x. Epub 2010 Aug 18. PMID: 20726938.; Jury CS, McHenry P, Burden AD, Lever R, Bilsland D. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol. 2006 Mar;31(2):196-9. doi: 10.1111/j.1365-2230.2006.02061.x. PMID: 16487089.
2 Bae YC. Van Voorhees AS, et al. “Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation.” J Am Acad Dermatol. 2012 Sep;67:459-77.; Bangsgaard N, Rørbye C, et al. “Treating psoriasis during pregnancy: Safety and efficacy of treatments.” Am J Clin Dermatol. 2015 Oct;16:389-98.
3 Bulur, I., Erdogan, H. K., Aksu, A. E., Karapınar, T., & Saracoglu, Z. N. (2018). The efficacy and safety of phototherapy in geriatric patients: a retrospective study. Anais brasileiros de dermatologia, 93(1), 33–38. https://doi.org/10.1590/abd1806-4841.20185468
4 Rácz, E., & Prens, E. P. (2017). Phototherapy of psoriasis, a chronic inflammatory skin disease. Advances in Experimental Medicine and Biology, 287–294. https://doi.org/10.1007/978-3-319-56017-5_24
5 Hearn RMR, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. British Journal of Dermatology. 2008;159:931-935. doi: 10.1111/j.1365-2133.2008.08776.x.
6 Fernández-Guarino M, Aboin González S, Gonzalez-Cantero A, Arsuaga C, Lázaro P (2020) Phototherapy with Narrow-Band Ultraviolet B in Adult Psoriasis: A Study in Clinical Practice. J Clin Exp Dermatol Res. 11:521. DOI: 10.35248/2155-9554.20.11.521
7 Zanolli, M. D. (2000). Psoriasis Narrow Band Ultraviolet B (NBUVB) Phototherapy by Skin Type. In Phototherapy treatment protocols: For psoriasis and other phototherapy response dermatoses (pp. 18–20). essay, Parthenon Publishing
8 CMS.gov. (2024, January 25). https://www.cms.gov/medicare/physician-fee-schedule/search?Y=0&T=4&HT=0&CT=3&H1=96910&M=5